Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MOV10 RNA helicase is an evolutionarily conserved, ATP-dependent RNA helicase involved in RNA silencing and regulation of retroelements. It is a component of the RNA-induced silencing complex (RISC), where it interacts with Argonaute proteins and participates in miRNA- and siRNA-mediated mRNA degradation. MOV10 restricts retrovirus replication and inhibits retrotransposition of human genomic elements such as LINE-1, Alu, and SVA by associating with their ribonucleoprotein complexes. It also interacts with critical neuronal RNA-binding proteins, including FMRP (fragile X mental retardation protein). MOV10 is essential for early embryonic development, particularly during gastrulation and in early neural development. Phosphorylation of specific residues controls its activity, and dysregulation may contribute to neurodevelopmental disorders or increased genomic instability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MOV10 RNA helicase (MOV10).